Related Experiment Video
Updated: May 10, 2026

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
Self-HER2Net: A generative self-supervised framework for HER2 classification in IHC histopathology of breast cancer
Genevieve Chyrmang1, Barun Barua1, Kangkana Bora1
1Department of Computer Science and Information Technology, Cotton University, Guwahati, Assam, India.
Abstract:
Breast cancer is a significant global health concern, where precise identification of proteins like Human Epidermal Growth Factor Receptor 2 (HER2) in cancer cells via Immunohistochemistry (IHC) is pivotal for treatment decisions. HER2 overexpression is evaluated through HER2 scoring on a scale from 0 to 3 + based on staining patterns and intensity. Recent efforts have been made to automate HER2 scoring using image processing and AI techniques. However, existing methods require large manually annotated datasets as these follow supervised learning paradigms. Therefore, we proposed a generative self-supervised learning (SSL) framework "Self-HER2Net" for the classification of HER2 scoring, to reduce dependence on large manually annotated data by leveraging one of best performing four novel generative self-supervised tasks, that we proposed. The first two SSL tasks HER2hsl and HER2hsv are domain-agnostic and the other two HER2dab and HER2hae are domain-specific SSL tasks focusing on domain-agnostic and domain-specific staining patterns and intensity representation. Our approach is evaluated under different budget scenarios (2 %, 15 %, & 100 % labeled datasets) and also out distribution test. For tile-level assessment, HER2hsv achieved the best performance with AUC-ROC of 0.965 ± 0.037. Our self-supervised learning approach shows potential for application in scenarios with limited annotated data for HER2 analysis.
More Related Videos
10:49Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
Published on: January 21, 2019
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024